Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Psychemedics Corporation

    NASDAQ: PMD · Real-Time Price · USD
    2.67
    0.00 (0.00%)
    At close: Jan 16, 2025, 9:00 PM

    Psychemedics Statistics

    Share Statistics

    Psychemedics has 5.89M shares outstanding. The number of shares has increased by 1.53% in one year.

    Shares Outstanding

    n/a
    		 5.89M

    Shares Change (YoY)

    n/a
    		 1.53%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 20.9%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 5,569

    FTD / Avg. Volume

    n/a
    		 12.99%

    Short Selling Information

    The latest short interest is 38.6K, so 0.65% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 38.6K

    Short % of Shares Out

    n/a
    		 0.65%

    Short % of Float

    n/a
    		 0.87%

    Short Ratio (days to cover)

    n/a
    		 1.92

    Valuation Ratios

    The PE ratio is -4.09 and the forward PE ratio is null. Psychemedics's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -4.09

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.77

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 2.55

    P/FCF Ratio

    n/a
    		 -10.38

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Psychemedics has an Enterprise Value (EV) of 17.32M.

    EV / Sales

    n/a
    		 0.78

    EV / EBITDA

    n/a
    		 -69.02

    EV / EBIT

    n/a
    		 -11.71

    EV / FCF

    n/a
    		 -10.58

    Financial Position

    The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.34.

    Current Ratio

    n/a
    		 1.45

    Quick Ratio

    n/a
    		 1.45

    Debt / Equity

    n/a
    		 0.34

    Debt / EBITDA

    n/a
    		 -9.16

    Debt / FCF

    n/a
    		 -1.4

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -62.26% and Return on Invested Capital is -39.35%.

    Return on Equity

    n/a
    		 -62.26%

    Return on Assets

    n/a
    		 -33.7%

    Return on Invested Capital

    n/a
    		 -39.35%

    Revenue Per Employee

    n/a
    		 $190,500

    Profits Per Employee

    n/a
    		 $-35,810.34

    Employee Count

    n/a
    		 116

    Asset Turnover

    n/a
    		 1.79

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 716K

    Effective Tax Rate

    n/a
    		 -20.83%

    Stock Price Statistics

    The stock price has increased by 0.75% in the last 52 weeks. The beta is 0.67, so Psychemedics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.67

    52-Week Price Change

    n/a
    		 0.75%

    50-Day Moving Average

    n/a
    		 2.13

    200-Day Moving Average

    n/a
    		 2.29

    Relative Strength Index (RSI)

    n/a
    		 50.24

    Average Volume (20 Days)

    n/a
    		 42,860

    Income Statement

    In the last 12 months, Psychemedics had revenue of 22.1M and earned -4.15M in profits. Earnings per share was -0.72.

    Revenue

    n/a
    		 22.1M

    Gross Profit

    n/a
    		 8.41M

    Operating Income

    n/a
    		 -2.92M

    Net Income

    n/a
    		 -4.15M

    EBITDA

    n/a
    		 -251K

    EBIT

    n/a
    		 -2.92M

    Earnings Per Share (EPS)

    n/a
    		 -0.72
    Full Income Statement

    Balance Sheet

    The company has 1.96M in cash and 2.3M in debt, giving a net cash position of -334K.

    Cash & Cash Equivalents

    n/a
    		 1.96M

    Total Debt

    n/a
    		 2.3M

    Net Cash

    n/a
    		 -334K

    Retained Earnings

    n/a
    		 -16.77M

    Total Assets

    n/a
    		 9.84M

    Working Capital

    n/a
    		 2.25M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -1.48M and capital expenditures -157K, giving a free cash flow of -1.64M.

    Operating Cash Flow

    n/a
    		 -1.48M

    Capital Expenditures

    n/a
    		 -157K

    Free Cash Flow

    n/a
    		 -1.64M

    FCF Per Share

    n/a
    		 -0.29
    Full Cash Flow Statement

    Margins

    Gross margin is 38.07%, with operating and profit margins of -13.22% and -18.8%.

    Gross Margin

    n/a
    		 38.07%

    Operating Margin

    n/a
    		 -13.22%

    Pretax Margin

    n/a
    		 -15.56%

    Profit Margin

    n/a
    		 -18.8%

    EBITDA Margin

    n/a
    		 -1.14%

    EBIT Margin

    n/a
    		 -13.22%

    FCF Margin

    n/a
    		 -7.41%

    Dividends & Yields

    PMD pays an annual dividend of $0.35, which amounts to a dividend yield of 5.68%.

    Dividend Per Share

    n/a
    		 $0.35

    Dividend Yield

    n/a
    		 5.68%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 -68.63%

    Earnings Yield

    n/a
    		 -24.45%

    FCF Yield

    n/a
    		 -9.63%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PMD.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 1, 2002. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Aug 1, 2002

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 0.83

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist